speb/financial-data huggingface dataset:
ALGS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 38849087.83
Net income (USD): -15863000
P/E ratio: 1.426963740312213
P/B ratio: 0.3813744314098914
Pays dividend: no
Net asset value (USD): 101866000
Net cash (USD): 90105000
Net cash to market cap %: 231.93594761939102
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -4.918672791518566 (Distress Zone)
Piotroski F-score: 4 (Weak)
ALGS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 52804585.400000006
Net income (USD): -31537000
P/B ratio: 0.7351020478053263
Pays dividend: no
Net asset value (USD): 71833000
Net cash (USD): 61165000
Net cash to market cap %: 115.83274357078845
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -7.057667016267536 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALGS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 50218238.36
Net income (USD): -19881000
P/B ratio: 0.9378697984872537
Pays dividend: no
Net asset value (USD): 53545000
Net cash (USD): 42856000
Net cash to market cap %: 85.33951289325952
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -9.270001116119808 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALGS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 25247950
Net income (USD): -23040000
EPS growth %: -153.47196435202378
Revenue growth %: 809.967845659164
Smoothed growth %: -153.47196435202378
P/B ratio: 1.2593820783918965
Pays dividend: no
Net asset value (USD): 31789000
Net cash (USD): 22140000
Net cash to market cap %: 87.69028772633025
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -14.621893551081685 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALGT — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Industrials | Industry: Airlines
Lynch category: Cyclical (confidence: High)
Market cap (USD): 4858914450
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ALGT — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Industrials | Industry: Airlines
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1766120524.9999998
Net income (USD): 2493000
P/E ratio: 708.4318190934616
P/B ratio: 1.4468120083755358
Pays dividend: no
Net asset value (USD): 1220698000
Net cash (USD): -2335547000
Net cash to market cap %: -132.24165434575877
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.3952828108358128 (Distress Zone)
Piotroski F-score: 4 (Weak)
ALGT — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Industrials | Industry: Airlines
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2180302800
Net income (USD): 117596000
EPS growth %: 4617.047733654232
Revenue growth %: 9.037508867948054
Smoothed growth %: 4617.047733654232
P/E ratio: 18.5406204292663
P/B ratio: 1.6411022460408262
PEG ratio: 0.0040156874043388
Pays dividend: no
Net asset value (USD): 1328560000
Net cash (USD): -2713434000
Net cash to market cap %: -124.45216324998528
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.372934672368797 (Distress Zone)
Piotroski F-score: 8 (Strong)
ALGT — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Industrials | Industry: Airlines
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2529710300
Net income (USD): -240238000
EPS growth %: -304.2909622776285
Revenue growth %: 0.1088508229751735
Smoothed growth %: 0.1088508229751735
P/B ratio: 2.322130417700883
Pays dividend: no
Net asset value (USD): 1089392000
Net cash (USD): -2559335000
Net cash to market cap %: -101.17107085344912
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.35668360642789 (Distress Zone)
Piotroski F-score: 5 (Neutral)
ALGT — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Industrials | Industry: Airlines
Lynch category: Cyclical (confidence: High)
Market cap (USD): 2291844425
Net income (USD): -44697000
Revenue growth %: 3.7407630137678707
Smoothed growth %: 3.7407630137678707
P/B ratio: 2.177158259371108
Pays dividend: no
Net asset value (USD): 1052677000
Net cash (USD): -2351069000
Net cash to market cap %: -102.58414464585658
Cyclical industry: yes | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.4962514907941498 (Distress Zone)
Piotroski F-score: 8 (Strong)
ALI2S.PA — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Industrials | Industry: Electrical Equipment & Parts
Lynch category:  (confidence: Low)
Market cap (USD): 14251188.020833336
P/B ratio: 1.1615256743270315
Pays dividend: no
Net asset value (USD): 8618408.333333334
Net cash (USD): -3114352.083333333
Net cash to market cap %: -21.853280433747457
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
ALI2S.PA — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Industrials | Industry: Electrical Equipment & Parts
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 11440878.823529413
P/E ratio: 20
P/B ratio: 0.8528318443971037
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 9800087.05882353
Net cash (USD): -1688671.7647058824
Net cash to market cap %: -14.759982958939702
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
ALKEM.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 8493999284.519829
P/B ratio: 5.970720768458315
Pays dividend: no
Net asset value (USD): 1308586956.5217392
Net cash (USD): -55818203.53559482
Net cash to market cap %: -0.6571486724436457
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ALKEM.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 6745969204.69133
Net income (USD): 37688800.561140984
P/E ratio: 44.74783691873944
P/B ratio: 4.641043731953551
Pays dividend: no
Net asset value (USD): 1338226560.6733692
Net cash (USD): -172965863.9233107
Net cash to market cap %: -2.563988341408756
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 8.077935316224915 (Safe Zone)
Piotroski F-score: 4 (Weak)
ALKEM.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 6843522289.9602165
Net income (USD): 78154692.25368594
P/E ratio: 21.890951434324986
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
ALKEM.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 7254266012.401353
Net income (USD): 87836527.62119503
P/E ratio: 35.615992166889995
P/B ratio: 4.659015687574986
Pays dividend: no
Net asset value (USD): 1410631341.6009018
Net cash (USD): -149321307.77903044
Net cash to market cap %: -2.0583930548419627
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.721586395927683 (Safe Zone)
Piotroski F-score: 2 (Weak)
ALKEM.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 7275470980.282946
Net income (USD): 72744792.24685307
P/E ratio: 26.319891147505782
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
ALKEM.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 7138294189.741416
Net income (USD): 26611911.82704536
EPS growth %: -29.390398657357235
Revenue growth %: 3.9049274678339594
Smoothed growth %: -29.390398657357235
P/E ratio: 0.290116856923794
P/B ratio: 4.395919173942265
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 1366661721.0682492
Net cash (USD): -162283806.69775325
Net cash to market cap %: -2.2734255885807357
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 6.859392649575115 (Safe Zone)
Piotroski F-score: 2 (Weak)
ALL — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category:  (confidence: Medium)
Market cap (USD): 47427232143.200005
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ALL — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category:  (confidence: Medium)
Market cap (USD): 48428599560.9
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ALL — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 52274468255.1
Net income (USD): 596000000
P/E ratio: 21.927209838548656
P/B ratio: 2.37050917173499
Pays dividend: no
Net asset value (USD): 18940000000
Net cash (USD): -85728000000
Net cash to market cap %: -163.99592929696843
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 4 (Weak)
ALL — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 51067164093.4
Net income (USD): 2109000000
P/E ratio: 18.878803731386324
P/B ratio: 2.127355304869819
Pays dividend: no
Net asset value (USD): 20901000000
Net cash (USD): -81254000000
Net cash to market cap %: -159.11202715582436
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 6 (Neutral)
ALL — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 54719967090.1
Net income (USD): 3746000000
P/E ratio: 8.482400727034568
P/B ratio: 1.9906132303867001
Pays dividend: no
Net asset value (USD): 24387000000
Net cash (USD): -83239000000
Net cash to market cap %: -152.11814704300087
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
ALL — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 53311874603
Net income (USD): 3832000000
P/E ratio: 5.184467042983565
P/B ratio: 1.7428446370590736
Pays dividend: no
Net asset value (USD): 26934000000
Net cash (USD): -83604000000
Net cash to market cap %: -156.8205969543892
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 6 (Neutral)
ALL — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Financial Services | Industry: Insurance - Property & Casualty
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 66921717760
Net income (USD): 2458000000
EPS growth %: 312.41610738255036
Revenue growth %: 3.000676381971346
Smoothed growth %: 312.41610738255036
P/E ratio: 4.490794888455707
P/B ratio: 1.6897348791021622
PEG ratio: 0.014374402543069825
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 28489000000
Net cash (USD): -86983000000
Net cash to market cap %: -129.9772374521906
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
ALLCARGO.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Industrials | Industry: Integrated Freight & Logistics
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 73128049.58459713
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
ALLCARGO.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Industrials | Industry: Integrated Freight & Logistics
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 79562728.38002436
Pays dividend: no
Net asset value (USD): 178974421.43727162
Net cash (USD): -333026796.589525
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 4 (Weak)
ALLCARGO.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Industrials | Industry: Integrated Freight & Logistics
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 17951792.780908983
EPS growth %: -77.43693165578254
Revenue growth %: -29.275511489006277
Smoothed growth %: -77.43693165578254
Pays dividend: no
Net asset value (USD): 107876244.1539753
Net cash (USD): -496647079.9856097
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
ALLCARGO.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Industrials | Industry: Integrated Freight & Logistics
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 7598784.194528875
EPS growth %: -57.67116807069053
Revenue growth %: -85.22792866063863
EPS 2-year CAGR %: -69.09582022198448
Smoothed growth %: -57.67116807069053
Pays dividend: no
Net asset value (USD): 105683890.57750759
Net cash (USD): -498204348.8426467
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 5 (Neutral)
ALLCARGO.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Industrials | Industry: Integrated Freight & Logistics
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 127936569.7329377
Net income (USD): 847816.871555744
EPS growth %: -88.84272997032642
Revenue growth %: -4.863079304599931
EPS 2-year CAGR %: -78.26812921361865
Smoothed growth %: -88.84272997032642
Pays dividend: no
Net asset value (USD): 46629927.93556592
Net cash (USD): -105235269.18185672
Net cash to market cap %: -82.25581583243243
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.8916043301093777 (Grey Zone)
Piotroski F-score: 7 (Neutral)
ALLT — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category:  (confidence: Low)
Market cap (USD): 581206416.12
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
ALLT — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 168295460.56
Net income (USD): -9099431.818181818
P/B ratio: 5.809381122171555
Pays dividend: no
Net asset value (USD): 18928693.181818184
Net cash (USD): -7280397.727272727
Net cash to market cap %: -4.32596203310971
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4977513916649676 (Grey Zone)
Piotroski F-score: 1 (Weak)
ALLT — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Turnaround (confidence: High)
Market cap (USD): 80723113.35
Net income (USD): -17349171.27071823
Revenue growth %: -26.20253421534623
Smoothed growth %: -26.20253421534623
P/B ratio: 5.872187575648574
Pays dividend: no
Net asset value (USD): 4700276.243093923
Net cash (USD): -9766574.585635358
Net cash to market cap %: -12.098857663342786
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1.087589772298136 (Distress Zone)
Piotroski F-score: 3 (Weak)
ALLT — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Speculative (confidence: Low)
Market cap (USD): 291092439.05
Net income (USD): -1607945.2054794522
Revenue growth %: -1.8387194023485436
Smoothed growth %: -1.8387194023485436
P/B ratio: 21.3312333620932
Pays dividend: no
Net asset value (USD): 4841369.863013699
Net cash (USD): -8758904.109589042
Net cash to market cap %: -3.008976852224098
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.416588379537757 (Safe Zone)
Piotroski F-score: 6 (Neutral)
ALLT — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Technology | Industry: Software - Infrastructure
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 480914063.17
Net income (USD): 1165094.3396226414
Revenue growth %: 26.97807593353027
Smoothed growth %: 26.97807593353027
P/E ratio: 412.7683457167612
P/B ratio: 13.491898728545214
Pays dividend: no
Net asset value (USD): 25634276.729559746
Net cash (USD): 6767610.062893081
Net cash to market cap %: 1.407238960383817
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 14.537119774133085 (Safe Zone)
Piotroski F-score: 8 (Strong)
ALLUX.PA — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Aluminum
Lynch category: Cyclical (confidence: High)
Market cap (USD): 116073044.625
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
ALLUX.PA — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Aluminum
Lynch category: Cyclical (confidence: High)
Market cap (USD): 98756926.21276596
Net income (USD): 6991489.361702128
P/E ratio: 14.125305940353012
P/B ratio: 0.8387378988073726
Pays dividend: no
Net asset value (USD): 114622340.42553192
Net cash (USD): -11539361.702127665
Net cash to market cap %: -11.684610026507702
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.975174654033273 (Grey Zone)
Piotroski F-score: 2 (Weak)
ALLUX.PA — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Aluminum
Lynch category: Cyclical (confidence: High)
Market cap (USD): 78117106.46666667
Net income (USD): 7244444.444444444
EPS growth %: 3.618042875498733
Revenue growth %: -4.31980231431589
Smoothed growth %: 3.618042875498733
P/E ratio: 10.783036168711657
P/B ratio: 0.6118034705652003
PEG ratio: 2.980350576200747
Pays dividend: no
Net asset value (USD): 124386666.66666666
Net cash (USD): -4651111.111111112
Net cash to market cap %: -5.954023800274511
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.3453419671557265 (Grey Zone)
Piotroski F-score: 5 (Neutral)
ALLUX.PA — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Aluminum
Lynch category: Cyclical (confidence: High)
Market cap (USD): 98672830.4375
Net income (USD): 8857291.666666668
EPS growth %: 22.26322852760739
Revenue growth %: -7.4938756617293105
EPS 2-year CAGR %: 12.555215142038278
Smoothed growth %: 12.555215142038278
P/E ratio: 11.14029368693402
P/B ratio: 0.7811866931114391
PEG ratio: 0.8873040852667896
Pays dividend: no
Net asset value (USD): 114543750
Net cash (USD): -7035416.666666664
Net cash to market cap %: -7.130044446351361
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4478674117424157 (Grey Zone)
Piotroski F-score: 7 (Neutral)
ALLUX.PA — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Aluminum
Lynch category: Cyclical (confidence: High)
Market cap (USD): 161729656.47058824
Net income (USD): 9041176.470588235
EPS growth %: 2.0760838735117555
Revenue growth %: 26.002364528721998
EPS 2-year CAGR %: 11.714598731904257
Smoothed growth %: 11.714598731904257
P/E ratio: 13.52766625938209
P/B ratio: 0.6843709556354441
PEG ratio: 1.1547699216141323
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 136702352.94117647
Net cash (USD): 4924705.882352933
Net cash to market cap %: 3.0450233988152497
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.0967403671404226 (Safe Zone)
Piotroski F-score: 6 (Neutral)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Medium)
Market cap (USD): 2040802643.7777774
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category:  (confidence: Low)
Market cap (USD): 1802175024.21875
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2240078422.228261
Net income (USD): 23478260.869565215
P/E ratio: 23.852686903356485
P/B ratio: 1.3736400376258082
Pays dividend: no
Net asset value (USD): 250978260.86956522
Net cash (USD): -566739130.4347825
Net cash to market cap %: -25.299968287317064
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.7621601934190854 (Distress Zone)
Piotroski F-score: 4 (Weak)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2680580333.470588
Net income (USD): 5857647.05882353
P/E ratio: 91.37540041419871
P/B ratio: 1.557298844683844
Pays dividend: no
Net asset value (USD): 320457647.0588235
Net cash (USD): -613635294.117647
Net cash to market cap %: -22.891882270999282
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 1.9820775030336069 (Grey Zone)
Piotroski F-score: 6 (Neutral)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2895641219.8235297
Net income (USD): 14730588.235294119
P/E ratio: 65.71072065879281
P/B ratio: 1.6685614784421394
Pays dividend: no
Net asset value (USD): 303411764.7058824
Net cash (USD): -595058823.5294118
Net cash to market cap %: -20.550157231346386
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.058176350945087 (Grey Zone)
Piotroski F-score: 7 (Neutral)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 3233594041.2352943
Net income (USD): 23029411.76470588
P/E ratio: 48.193610326974024
P/B ratio: 1.8482227795544988
Pays dividend: no
Net asset value (USD): 325689411.7647059
Net cash (USD): -601389411.7647059
Net cash to market cap %: -18.598172933760225
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.4313586835761427 (Grey Zone)
Piotroski F-score: 7 (Neutral)
ALM.MC — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 2801559540.229885
Net income (USD): 17586206.896551725
EPS growth %: -25.095785440613017
Revenue growth %: 8.075706990964504
Smoothed growth %: -25.095785440613017
P/E ratio: 72.35329703569268
P/B ratio: 1.726647720976516
Dividend yield: 0.02
Pays dividend: yes
Net asset value (USD): 302068965.51724136
Net cash (USD): -587816091.954023
Net cash to market cap %: -20.981745471159577
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.150292748315036 (Grey Zone)
Piotroski F-score: 6 (Neutral)
ALM.V — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1805967.716535433
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
ALM.V — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1484080.5294117646
Net income (USD): -329172.0588235294
Pays dividend: no
Net asset value (USD): -1795565.4411764704
Net cash (USD): -1805133.8235294116
Net cash to market cap %: -121.63314508579266
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1168.400888324057 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALM.V — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 556019.1515151515
Net income (USD): -500060.606060606
Pays dividend: no
Net asset value (USD): -2350037.121212121
Net cash (USD): -2353423.484848485
Net cash to market cap %: -423.26302582121656
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -3767.774647031479 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALM.V — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 577404.5034965036
Net income (USD): -5974.825174825175
Pays dividend: no
Net asset value (USD): -2175239.8601398603
Net cash (USD): -2178453.146853147
Net cash to market cap %: -377.2837124860316
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -1318.826457850733 (Distress Zone)
Piotroski F-score: 4 (Weak)
ALM.V — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Basic Materials | Industry: Gold
Lynch category: Cyclical (confidence: High)
Market cap (USD): 1339316.2043795618
Net income (USD): -604627.7372262774
Pays dividend: no
Net asset value (USD): -2837469.343065693
Net cash (USD): -2839951.824817518
Net cash to market cap %: -212.04490885206047
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -4270.132463429245 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALMS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 1318254528.96
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
ALMS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 970176085.9200001
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
ALMS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 757872922.0799999
Net income (USD): -98963000
P/B ratio: 4.502732524210701
Pays dividend: no
Net asset value (USD): 168314000
Net cash (USD): 115765000
Net cash to market cap %: 15.274988276699512
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 0.3164893558161989 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALMS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 370296216
Net income (USD): 59321000
P/E ratio: 1.5605612514960974
P/B ratio: 0.762982929035475
Pays dividend: no
Net asset value (USD): 434368000
Net cash (USD): 360723000
Net cash to market cap %: 97.41471406232247
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.26271319775615215 (Distress Zone)
Piotroski F-score: 5 (Neutral)
ALMS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 492493967.28000003
Net income (USD): -110752000
P/B ratio: 1.2799597874071207
Pays dividend: no
Net asset value (USD): 333814000
Net cash (USD): 274483000
Net cash to market cap %: 55.733271519232
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 0.572364367261446 (Distress Zone)
Piotroski F-score: 1 (Weak)
ALMS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 1204697022.72
Net income (USD): -92931000
P/B ratio: 3.9983704541366163
Pays dividend: no
Net asset value (USD): 250338000
Net cash (USD): 197858000
Net cash to market cap %: 16.42388054992204
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 3.4133329142447892 (Safe Zone)
Piotroski F-score: 4 (Weak)
ALMS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 3569775616
Net income (USD): -93053000
Revenue growth %: -25.179751564199805
Smoothed growth %: -25.179751564199805
P/B ratio: 4.795604653372627
Pays dividend: no
Net asset value (USD): 516062000
Net cash (USD): 418376000
Net cash to market cap %: 11.719952316465147
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 18.752801716506916 (Safe Zone)
Piotroski F-score: 5 (Neutral)
ALNFL.PA — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 26004496.604166668
P/B ratio: 25.566929262722375
Pays dividend: no
Net asset value (USD): 865775
Net cash (USD): -541558.3333333335
Net cash to market cap %: -2.0825564961967395
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
ALNFL.PA — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 12970412.94117647
P/B ratio: 48.84398976948688
Pays dividend: no
Net asset value (USD): 175474.11764705883
Net cash (USD): -1359090.5882352944
Net cash to market cap %: -10.478391045829103
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 156067798.26812977
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 80321953.15696649
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 56410047.566793896
Net income (USD): -310305.3435114504
P/B ratio: 4.4118367326378
Pays dividend: no
Net asset value (USD): 12786068.702290075
Net cash (USD): -16477385.496183205
Net cash to market cap %: -29.21001879438711
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.785903131531761 (Distress Zone)
Piotroski F-score: 3 (Weak)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 65447190.719960265
Net income (USD): -312015.88877855014
P/B ratio: 5.036476818411077
Pays dividend: no
Net asset value (USD): 12994637.537239324
Net cash (USD): -17030983.11817279
Net cash to market cap %: -26.02248153178351
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.005406902021683 (Grey Zone)
Piotroski F-score: 4 (Weak)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 89073696.72344689
Net income (USD): -33366.73346693387
P/B ratio: 6.810875676524671
Pays dividend: no
Net asset value (USD): 13078156.31262525
Net cash (USD): -16835070.140280563
Net cash to market cap %: -18.90015881180899
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.8278446623235323 (Grey Zone)
Piotroski F-score: 8 (Strong)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 71967134.61155379
Net income (USD): -442388.0597014925
P/B ratio: 5.7369119704148845
Pays dividend: no
Net asset value (USD): 12544577.114427859
Net cash (USD): -16999701.492537312
Net cash to market cap %: -23.62147886572677
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.2368968715054085 (Grey Zone)
Piotroski F-score: 3 (Weak)
ALNG.OL — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Market cap (USD): 78760636.38232271
Net income (USD): -653956.834532374
Revenue growth %: -13.622104979692123
Smoothed growth %: -13.622104979692123
P/B ratio: 6.328430639623759
Pays dividend: no
Net asset value (USD): 12303288.797533402
Net cash (USD): -17365981.500513874
Net cash to market cap %: -22.049061940301375
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.4413383976472485 (Grey Zone)
Piotroski F-score: 5 (Neutral)
ALNY — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 36719962952.189995
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ALNY — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Medium)
Market cap (USD): 31416843552.63
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ALNY — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 36051064961.46
Net income (USD): -18251000
P/B ratio: 312.3061892966604
Pays dividend: no
Net asset value (USD): 115435000
Net cash (USD): -1466154000
Net cash to market cap %: -4.066881246274905
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 3.6170524975037264 (Safe Zone)
Piotroski F-score: 1 (Weak)
ALNY — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 43537114929.57
Net income (USD): -66277000
P/B ratio: 173.73774369219163
Pays dividend: no
Net asset value (USD): 250591000
Net cash (USD): -1457843000
Net cash to market cap %: -3.348506216726471
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 4.554230387149719 (Safe Zone)
Piotroski F-score: 5 (Neutral)
ALNY — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 60881733288
Net income (USD): 251084000
P/E ratio: 365.5331137155071
P/B ratio: 260.29625936535354
Pays dividend: no
Net asset value (USD): 233894000
Net cash (USD): -1893144000
Net cash to market cap %: -3.109543532613493
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.945011274783582 (Safe Zone)
Piotroski F-score: 8 (Strong)
ALNY — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 53091274653.45
Net income (USD): 186419000
P/E ratio: 150.4108638103265
P/B ratio: 67.27431479600241
Pays dividend: no
Net asset value (USD): 789176000
Net cash (USD): -1268671000
Net cash to market cap %: -2.3896035804021873
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 6.6693750271935395 (Safe Zone)
Piotroski F-score: 5 (Neutral)
ALNY — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 36284710912
Net income (USD): 205991000
Revenue growth %: 96.43160677831465
Smoothed growth %: 96.43160677831465
P/E ratio: 83.3425692695214
P/B ratio: 41.07878613002846
Pays dividend: no
Net asset value (USD): 1075380000
Net cash (USD): -1044944000
Net cash to market cap %: -2.879846562741715
Cyclical industry: no | Hot industry: yes | Large cap: yes | Small cap: no
Altman Z-score: 4.668624933185341 (Safe Zone)
Piotroski F-score: 8 (Strong)
ALOPM.PA — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
ALOPM.PA — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 34483568.61702128
Net income (USD): -245937.2340425532
P/B ratio: 2.7513385957633476
Pays dividend: no
Net asset value (USD): 11688202.127659576
Net cash (USD): 7219301.063829788
Net cash to market cap %: 20.935481312877524
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 2.219263377180323 (Grey Zone)
Piotroski F-score: 1 (Weak)
ALOPM.PA — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 38346629.833333336
Net income (USD): -8989638.977777777
Revenue growth %: 34.573924472473934
Smoothed growth %: 34.573924472473934
P/B ratio: 9.351061110185965
Pays dividend: no
Net asset value (USD): 2826257.5555555555
Net cash (USD): -2894823.5444444455
Net cash to market cap %: -7.549095075698362
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -0.2664770483361231 (Distress Zone)
Piotroski F-score: 3 (Weak)
ALOPM.PA — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: High)
Market cap (USD): 14101920.15625
Net income (USD): -7510020.229166667
Revenue growth %: -81.8965198358461
Smoothed growth %: -81.8965198358461
Pays dividend: no
Net asset value (USD): -1572745.6145833335
Net cash (USD): -6112017.25
Net cash to market cap %: -43.341737736978615
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: -3.077541998588906 (Distress Zone)
Piotroski F-score: 1 (Weak)
ALOPM.PA — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: High)
Market cap (USD): 7828843.529411765
Net income (USD): 6446720.105882353
Revenue growth %: 42.45734703154831
Smoothed growth %: 42.45734703154831
P/E ratio: 1.607843137254902
P/B ratio: 0.14784694527299846
Pays dividend: no
Net asset value (USD): 60976605.22352941
Net cash (USD): 47062896.83529412
Net cash to market cap %: 601.1474959039101
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 6 (Neutral)
ALPA.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 19339704.866147965
Net income (USD): 1858341.025979164
P/E ratio: 10.40697299138506
P/B ratio: 1.2047279744223338
Pays dividend: no
Net asset value (USD): 16039417.117235923
Net cash (USD): 4848529.605696955
Net cash to market cap %: 25.070339176601266
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.777366212917394 (Safe Zone)
Piotroski F-score: 2 (Weak)
ALPA.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 13787871.863580998
Net income (USD): 1532618.7576126675
EPS growth %: -17.527583140714054
Revenue growth %: -22.76693652471057
Smoothed growth %: -17.527583140714054
P/E ratio: 8.996282862319992
P/B ratio: 0.8411393286396315
Pays dividend: no
Net asset value (USD): 16381741.778319124
Net cash (USD): 5864750.3045067
Net cash to market cap %: 42.535573020501666
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.101970681197069 (Safe Zone)
Piotroski F-score: 6 (Neutral)
ALPA.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 21012835.292706337
Net income (USD): 2011811.967861854
EPS growth %: 31.266302064292695
Revenue growth %: 14.975464657957538
EPS 2-year CAGR %: 4.047341068492938
Smoothed growth %: 4.047341068492938
P/E ratio: 10.44473123153686
P/B ratio: 1.1534888743428864
PEG ratio: 2.5806402412797014
Pays dividend: no
Net asset value (USD): 18209557.50089939
Net cash (USD): 7481892.313227005
Net cash to market cap %: 35.60629590916752
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 5.641443442701432 (Safe Zone)
Piotroski F-score: 6 (Neutral)
ALPA.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 25438279.379157428
Net income (USD): 2279997.6619125553
EPS growth %: 13.330554660917345
Revenue growth %: 1.5817347937646684
EPS 2-year CAGR %: 21.969187999403395
Smoothed growth %: 21.969187999403395
P/E ratio: 11.157151519979523
P/B ratio: 1.2692868093880543
PEG ratio: 0.5078545242674655
Pays dividend: no
Net asset value (USD): 20035749.35702595
Net cash (USD): 7192646.714987141
Net cash to market cap %: 28.274894727669185
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.479192877839909 (Safe Zone)
Piotroski F-score: 5 (Neutral)
ALPA.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 14977713.26833404
Net income (USD): 1590695.2098346758
EPS growth %: -30.232594690455272
Revenue growth %: -14.701854603430661
EPS 2-year CAGR %: -11.079930606281385
Smoothed growth %: -30.232594690455272
P/E ratio: 0.06865375396835248
P/B ratio: 0.5224445774591874
Pays dividend: no
Net asset value (USD): 19737664.264518864
Net cash (USD): 9002713.013988977
Net cash to market cap %: 60.107393249559394
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.7560727129449125 (Grey Zone)
Piotroski F-score: 3 (Weak)
ALPRI.PA — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Turnaround (confidence: High)
Market cap (USD): 15040946.711111112
Net income (USD): -2275555.5555555555
P/B ratio: 1.4496521781966165
Pays dividend: no
Net asset value (USD): 2141111.111111111
Net cash (USD): -35981111.11111111
Net cash to market cap %: -239.2210530506766
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.340704671453722 (Distress Zone)
Piotroski F-score: 2 (Weak)
ALPRI.PA — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Turnaround (confidence: High)
Market cap (USD): 8934534.652173912
Net income (USD): -545652.1739130435
Revenue growth %: 14.590331765684486
Smoothed growth %: 14.590331765684486
P/B ratio: 0.9713746017489953
Pays dividend: no
Net asset value (USD): 1564130.4347826086
Net cash (USD): -31811956.521739125
Net cash to market cap %: -356.0561099172499
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.7056356909853077 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ALPRI.PA — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 8492230.956521738
Net income (USD): 717204.3010752688
Revenue growth %: -10.72296761284619
Smoothed growth %: -10.72296761284619
P/E ratio: 11.840741813441104
P/B ratio: 0.8654147260097763
Pays dividend: no
Net asset value (USD): 2926881.7204301073
Net cash (USD): -26412903.225806452
Net cash to market cap %: -311.0243157661917
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.9105342041189923 (Grey Zone)
Piotroski F-score: 8 (Strong)
ALPRI.PA — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 8846073.913043479
Net income (USD): 1326086.956521739
EPS growth %: 84.89668209373575
Revenue growth %: 7.259400085915782
Smoothed growth %: 84.89668209373575
P/E ratio: 6.670809836065574
P/B ratio: 0.7870781431334621
PEG ratio: 0.07857562476587988
Pays dividend: no
Net asset value (USD): 4310869.565217391
Net cash (USD): -27165217.391304348
Net cash to market cap %: -307.0878409827597
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.0264136470204996 (Grey Zone)
Piotroski F-score: 7 (Neutral)
ALQWA.PA — Peter Lynch category analysis (annual, as of 2021-09-30)
Sector: Communication Services | Industry: Advertising Agencies
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 51420667.6627907
Net income (USD): 5211052.325581395
P/E ratio: 9.867616836308338
P/B ratio: 1.36660043226353
Pays dividend: no
Net asset value (USD): 5591632.558139535
Net cash (USD): -12867881.395348836
Net cash to market cap %: -25.024726399381937
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.692941482116149 (Grey Zone)
Piotroski F-score: 2 (Weak)